Initial Safety and Feasibility of Steerable Ureteroscopic Renal Evacuation: A Novel Approach for the Treatment of Urolithiasis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Endourology"
DOI: 10.1089/end.2021.0759
Abstract: Background: There is a need to reliably render urolithiasis patients completely stone free with minimal morbidity. We report on the initial safety and feasibility with steerable ureteroscopic renal evacuation (SURE) in a prospective study using… read more here.
Keywords: safety feasibility; initial safety; stone; feasibility steerable ... See more keywords
Initial safety outcomes for the Rigicon Infla10® inflatable penile prosthesis
Sign Up to like & getrecommendations! Published in 2023 at "BJU International"
DOI: 10.1111/bju.15960
Abstract: To analyse data from patient information forms (PIFs) submitted to the manufacturer of a new three‐piece inflatable penile prosthesis (IPP), the Rigicon Infla10®, to summarize early outcomes. read more here.
Keywords: inflatable penile; penile prosthesis; rigicon infla10; initial safety ... See more keywords
Initial safety results from a randomized, phase II study of high-risk colorectal cancer patients (stage IIIC) treated with either regorafenib or standard of care (no treatment) after adjuvant FOLFOX.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15152
Abstract: e15152Background: Standard adjuvant therapy for colorectal cancer (CRC) is fluoropyrimidine or FOLFOX. The stage IIIC relapse rate is high with a median 5 year survival of only 28%. The multi-kinas... read more here.
Keywords: colorectal cancer; results randomized; initial safety; safety results ... See more keywords
Initial safety run-in findings with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e16537
Abstract: e16537Background: Bavituximab, an investigational, chimeric monoclonal antibody designed to inhibit the immunosuppressive effects of phosphatidylserine (PS), is being evaluated in combination with ... read more here.
Keywords: findings bavituximab; plus pembrolizumab; run findings; bavituximab plus ... See more keywords